Company news

EchoIQ Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

EIQ signs integration agreement with Flagship US Hospital

November 17, 2024

US Based CEO Appointed to Execute Commercialisation Strategy

October 8, 2024

Major Milestone Achieved with FDA Clearance for EchoSolv AS

October 7, 2024

Echo IQ Raises $7.1 million

September 6, 2024

Groundbreaking study results for Heart Failure AI solution

September 3, 2024

Strategic Integration Partnership Agreement with ScImage Inc

July 4, 2024

Validation of EIQ AI at Leading Scientific Conference

June 5, 2024

Investor Presentation

May 22, 2024

Echo IQ Commences New Heart Failure Clinical Study Using AI

May 20, 2024

US FDA Application Lodged

May 6, 2024

Quarterly Report

April 30, 2024

Appendix 4C Cash Flow Report

April 30, 2024

Management Update

April 1, 2024

Completion of US Reader Study

March 27, 2024

Receipt of Research & Development Tax Incentive

March 7, 2024

Appendix 4D 31 December 2023

February 28, 2024

RSH: Cardiovascular AI platform integrated into RPM program

January 24, 2024

EIQ Licenses Software to Respiri - Remote Patient Mon.

January 24, 2024

EIQ Appoints Kimber Rothwell as CEO

January 15, 2024

Business Progress Update

December 13, 2023

Ord Minnett Healthcare Forum

October 29, 2023

Quarterly Activities Report

October 24, 2023

EIQ Investor Presentation updated

October 15, 2023

Paid Pilot with Australias Largest Cardiology Provider

August 28, 2023

Significant Expansion of EchoSolv Solutions Suite

August 20, 2023

Echo IQ Advances Global Regulatory Compliance Strategy

August 1, 2023

Launch of new echosolv solution for mitral regurgitation

July 18, 2023

Echo iq secures maiden australian hospital sale of echosolv

June 21, 2023

US Cardiovascular Facilities Access EchoSolv via Studycast

June 12, 2023

Echo IQ Delivers on Commercialisation

May 8, 2023

HYD: Hydrix signs agreement to sell EIQ's EchoSolv platform

May 1, 2023

Echo IQ Expands Commercial Footprint

May 1, 2023

Quarterly Activities/Appendix 4C Cash Flow Report

April 28, 2023

Flagship Clinical Trial Results At St Vincent Hospitals

April 19, 2023

Appendix 4D 31 December 2022

February 28, 2023

Amendment to Quarterly Report

February 1, 2023

Quarterly Activities/Appendix 4C Cash Flow Report - Dec

January 24, 2023

Positive Interim Results From Clinical Trial at St Vincents

December 14, 2022

Echo IQ Launches EchoSolv for Immediate Distribution

December 6, 2022

Echo IQ Announces Positive Results From US Clinical Study

November 30, 2022

Amendment to Appendix 4C

November 11, 2022

Quarterly Activities/Appendix 4C Cash Flow Report - Sept

October 28, 2022

Reinstatement to Official Quotation

October 12, 2022

Echo IQ Selected for HeartX Accelerator & Funding

October 11, 2022

Suspension from Official Quotation

October 6, 2022

New Research Presented at Leading Cardiology Conference

August 30, 2022

New Clinical Study with World-Leading US Teaching Hospital

July 26, 2022

Updated Appendix 4C Quarterly Cash Flow Report

July 19, 2022

Quarterly Activities/Appendix 4C Cash Flow Report - June

July 18, 2022

Presentation of Research Findings Behind Echo IQ Algorithm

July 6, 2022

← Newer news releases · Older news releases →

Decks

The 5 newest of 11 decks. Every deck is listed under its year.